{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:15:38Z","timestamp":1788304538473,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synovial sarcoma (SS) is a rare, aggressive malignant neoplasm with a high rate of metastasis despite its indolent nature. A distinct SS18::SSX fusion oncogene characterizes SS. The monophasic subtype is the most common and consists of spindle cells. Due to its rarity and subtle clinical presentation, SS can be challenging to identify, leading to misdiagnosis or delays in treatment. The present case highlights the importance of awareness and vigilance among healthcare providers when encountering slow-growing, seemingly benign soft-tissue tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 43-year-old Haitian man experiencing homelessness with a history of psychiatric disorder, tuberculosis, and substance use presented to the emergency department with right leg pain and intermittent chest pain. Physical examination revealed a large, tender mass on his calf, initially considered benign in past encounters. However, further imaging (CT and MRI scans) showed a large 14.3\u00a0cm, lobulated, heterogeneous soleus intramuscular mass with multiple peripheral and internal calcifications suggestive of soft-tissue sarcoma. In addition, a CT chest revealed multifocal pulmonary nodules highly suspicious for metastatic disease. Histologic examination of lung biopsies showed cells positive for vimentin, BCL-2, and TLE-1, consistent with monophasic SS; molecular confirmation of the SS18::SSX fusion was not obtained. Systemic AIM chemotherapy (doxorubicin, ifosfamide, and mesna) was planned. However, the patient declined further care and was lost to follow-up. He was subsequently reported to have died from pulmonary complications of metastatic disease approximately 6 months later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the complexity of diagnosing SS, given its subtle clinical findings, slow growth, and atypical presentation. Multidisciplinary care is essential for optimizing diagnosis and treatment outcomes. Prompt recognition and comprehensive care can improve patients\u2019 prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-026-06267-6","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T12:05:36Z","timestamp":1782043536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic challenges in synovial sarcoma: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9381-0065","authenticated-orcid":false,"given":"Johan","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vielka","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Recine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natassja","family":"Gangeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"issue":"5","key":"6267_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101618","volume":"8","author":"JY Blay","year":"2023","unstructured":"Blay JY, von Mehren M, Jones RL, et al. Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies. ESMO Open. 2023;8(5): 101618. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101618.","journal-title":"ESMO Open"},{"issue":"19","key":"6267_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194860","volume":"15","author":"EB Cho","year":"2023","unstructured":"Cho EB, Lee SK, Kim JY, Kim Y. Synovial sarcoma in the extremity: diversity of imaging features for diagnosis and prognosis. Cancers. 2023;15(19): 4860. https:\/\/doi.org\/10.3390\/cancers15194860.","journal-title":"Cancers"},{"issue":"3","key":"6267_CR3","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/curroncol28030177","volume":"28","author":"AM Gazendam","year":"2021","unstructured":"Gazendam AM, Popovic S, Munir S, Parasu N, Wilson D, Ghert M. Synovial sarcoma: a clinical review. Curr Oncol. 2021;28(3):1909\u201320. https:\/\/doi.org\/10.3390\/curroncol28030177.","journal-title":"Curr Oncol"},{"issue":"8","key":"6267_CR4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1245\/s10434-017-5855-x","volume":"24","author":"M El Beaino","year":"2017","unstructured":"El Beaino M, Araujo DM, Lazar AJ, Lin PP. Synovial sarcoma: advances in diagnosis and treatment. Identification of new biologic targets to improve multimodal therapy. Ann Surg Oncol. 2017;24(8):2145\u201354. https:\/\/doi.org\/10.1245\/s10434-017-5855-x.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6267_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cell.2013.02.036","volume":"153","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Crabtree GR. Reversible disruption of mSWI\/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell. 2013;153(1):71\u201385. https:\/\/doi.org\/10.1016\/j.cell.2013.02.036.","journal-title":"Cell"},{"issue":"6","key":"6267_CR6","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2018.05.002","volume":"33","author":"MJ McBride","year":"2018","unstructured":"McBride MJ, Pulice JL, Beird HC, et al. The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell. 2018;33(6):1128-1141.e7. https:\/\/doi.org\/10.1016\/j.ccell.2018.05.002.","journal-title":"Cancer Cell"},{"key":"6267_CR7","unstructured":"WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. 5th ed. International Agency for Research on Cancer. 2020;3."},{"issue":"3","key":"6267_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1530\/EOR-23-0193","volume":"9","author":"C Li","year":"2024","unstructured":"Li C, Krasniqi F, Donners R, Kettelhack C, Krieg AH. Synovial sarcoma: the misdiagnosed sarcoma. EFORT Open Rev. 2024;9(3):190\u2013201. https:\/\/doi.org\/10.1530\/EOR-23-0193.","journal-title":"EFORT Open Rev"},{"key":"6267_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-017-0083-x","volume":"5","author":"R de Necochea-Campion","year":"2017","unstructured":"de Necochea-Campion R, Zuckerman LM, Mirshahidi HR, Khosrowpour S, Chen CS, Mirshahidi S. Metastatic biomarkers in synovial sarcoma. Biomark Res. 2017;5: 4. https:\/\/doi.org\/10.1186\/s40364-017-0083-x.","journal-title":"Biomark Res"},{"issue":"11","key":"6267_CR10","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/2159-8290.CD-13-0138","volume":"3","author":"W Barham","year":"2013","unstructured":"Barham W, Frump AL, Sherrill TP, et al. Targeting the Wnt pathway in synovial sarcoma models. Cancer Discov. 2013;3(11):1286\u2013301. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0138.","journal-title":"Cancer Discov"},{"issue":"12","key":"6267_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-021-00914-4","volume":"22","author":"M Fiore","year":"2021","unstructured":"Fiore M, Sambri A, Spinnato P, et al. The biology of synovial sarcoma: state-of-the-art and future perspectives. Curr Treat Options Oncol. 2021;22(12): 109. https:\/\/doi.org\/10.1007\/s11864-021-00914-4.","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"6267_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(11):1348\u201365. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.006.","journal-title":"Ann Oncol"},{"key":"6267_CR13","doi-asserted-by":"publisher","first-page":"7192347","DOI":"10.1155\/2020\/7192347","volume":"2020","author":"M El Beaino","year":"2020","unstructured":"El Beaino M, Jupiter DC, Assi T, et al. Diagnostic value of TLE1 in synovial sarcoma: a systematic review and meta-analysis. Sarcoma. 2020;2020:7192347. https:\/\/doi.org\/10.1155\/2020\/7192347.","journal-title":"Sarcoma"},{"issue":"10435","key":"6267_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(24)00319-2","volume":"403","author":"SP D'Angelo","year":"2024","unstructured":"D\u2019Angelo SP, Araujo DM, Abdul Razak AR, et al. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. Lancet. 2024;403(10435):1460\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(24)00319-2.","journal-title":"Lancet"},{"key":"6267_CR15","unstructured":"US Food and Drug Administration. FDA approves first gene therapy to treat adults with metastatic synovial sarcoma. 2024. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treat-adults-metastatic-synovial-sarcoma. Accessed 30 May 2026."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06267-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06267-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06267-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:37:07Z","timestamp":1788302227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06267-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6267"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06267-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In accordance with institutional policy, this single de-identified case report was determined to be exempt from formal Institutional Review Board (IRB) review at Mount Sinai Medical Center of Florida. Written informed consent for publication of his clinical information and accompanying images was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"515"}}